phase readout
saveNCT07018713: A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Merz Therapeutics GmbH. Phase: PHASE3. Conditions: Chronic Migraine
view source ↗
comments(0)
5-min edit window · permanent after that